The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection
Open Access
- 1 January 2013
- journal article
- review article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 19, 599-605
Abstract
Erythropoietin (EPO) is traditionally described as a hematopoietic cytokine or growth hormone regulating proliferation, differentiation, and survival of erythroid progenitors. The use of EPO in patients with chronic kidney disease (CKD) was a milesto...Keywords
This publication has 72 references indexed in Scilit:
- Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial InfarctionJAMA, 2011
- Regulation of erythropoietin productionThe Journal of Physiology, 2011
- Epoetin Delta Reduces Oxidative Stress in Primary Human Renal Tubular CellsJournal of Biomedicine and Biotechnology, 2010
- Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney diseaseKidney International, 2010
- Erythropoietin receptor response circuitsCurrent Opinion in Hematology, 2010
- Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient SurvivalAmerican Journal of Kidney Diseases, 2009
- Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD PatientsClinical Journal of the American Society of Nephrology, 2009
- TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cellsExperimental Cell Research, 2009
- Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of ErythropoiesisMediators of Inflammation, 2009
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002